23andMe started out by testing for genetic markers of diseases and medical conditions before rolling that back in response to the governmental concerns. It has since started slowly adding more health-related features with approval from the FDA. In April, 23andMe got approval to offer risk analysis for ten genetically linked diseases. The company now offers two options: Health + Ancestry ($199) and Ancestry ($99). The Health + Ancestry plan includes testing for genetic health risks and carrier status, as well as reports on your genetic weight, hair loss, and other traits.
You might want to stay away from DNA tests if you or any of your close relatives have committed a crime. Although ancestry DNA testing companies don’t typically share database information with law enforcement, consumer DNA tests may result in future identification. For example, FamilyTreeDNA, which has a database of close to a million samples, has agreed to give the FBI limited access to the company's DNA database. This access consists mainly of consumer-level insights, like matches with other members of the FamilyTreeDNA community who have enabled family matching; by law, however, more in-depth investigation requires a subpoena.
This is one of the most common questions and the most difficult to answer. There are approximately forty companies currently offering DNA testing to determine genealogy and ethnicity. None of these companies have shared their data, no standards of accuracy have been agree on and independent scientists have not yet validated these methods. Some experts believe the results are valid, others feel they must be viewed with some skepticism. Once you receive your results, you must decide on the validity based on your knowledge of your family history.
The companies providing ancestry DNA tests are making most of their money from selling the genetic information as opposed to running the tests. Companies purchase this information to increase the size of their genetic databases. Nearly half the companies selling ancestry information are selling to more than just one company. These are sometimes pharmaceutical companies attempting to understand how specific human genome sections can help develop new drugs. Certain mutations will impact the effectiveness of these drugs. The original DNA sample is only destroyed by roughly ten percent of these companies. Most companies keep or sell the sample. This means it is both your data and saliva being sold.
In Newman’s view, the genie is out of the bottle with home genetic-testing kits. He says that while the kits could potentially provide data in the future, right now, they lack “clinical utility” – they look at genetic variants that, individually, have a very low chance of predicting specific health risks, as there are too many variables: “It’s like the Opportunity Knocks clap-o-meter, with some people further along the scale, and therefore more likely to get the condition and then people at the other end of the scale, who are unlikely to get it.”
If you are concerned about your data being sold, your concern may be valid. In the past, records have been sold and de-anonymized. It is possible for genetic information to be used to find the name of the individual the DNA came from. This can happen regardless of whether or not your name was in the database. This scenario has occurred in the past.
The spit is for one of the home genetic-testing kits I’m sampling. A growing number of these kits (brands such as 23andMe, DNAFit, Thriva, MyHeritage DNA, and Orig3n) promise to unlock the mystery of your genomes, variously explaining everything from ancestry, residual Neanderthal variants, “bioinformatics” for fitness, weight loss and skincare, to more random genetic predispositions, denoting, say, the dimensions of your earlobes or the consistency of your earwax.